DiaSys Enters into Distribution Agreement with Largest Clinical Distributor in Chile; Company Continues Rapid Expansion in Latin America Through Entrance into Fourth Market in Region.WATERBURY, Conn. -- DiaSys Corporation (AMEX AMEX See: American Stock Exchange : DYX DYX Dyslexia ), a global diagnostics products company, announced today that it has entered into an agreement with Galenica, the largest diagnostics distributor in Chile, to distribute its products throughout the country. Founded in 1985, Galenica has twenty technical support personnel located in two offices in the country supporting its twelve person sales force. Galenica exclusively represents companies such as Beckman Coulter This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. and Bio-Rad Instrumentation Laboratory. Its annual revenue is approximately $8 million "We continue to rapidly enter new markets through leading diagnostics distributors," said Jose Puig, DiaSys Corporation's Sales Manager sales manager n → gerente m/f de ventas sales manager n → directeur commercial sales manager sale n → for Latin America. "Galenica has a strong track record in the medical community in Chile, and we believe that this agreement will help us reach many of the largest potential customers for our innovative medical tests. The combination of exciting new products from the recently announced agreements to acquire Biocheck and Evernew Biotech, along with new market opportunities has positioned DiaSys for strong growth." Previously, DiaSys entered into distribution agreements with Tecnodiagnsostica, the largest distributor of clinical diagnostic products in Costa Rica, Repreclin S.A., a large clinical diagnostics distributor based in Venezuela and Grupo Mex Lab, a leading Mexican-based distributor of diagnostics products. DiaSys Corporation designs, develops, manufactures and distributes proprietary medical laboratory equipment, consumables and infectious disease Infectious disease A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions. test kits to healthcare and veterinary laboratories worldwide. Headquartered in Waterbury, Connecticut, the Company operates in Europe through its wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. based in Wokingham, England. DiaSys, Parasep and Urisep are registered trademarks of DiaSys Corporation. This press release contains forward-looking statements within the meaning of, and made pursuant to, the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The forward looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or events, or timing of events, relating to the Company to materially differ from those expressed or implied by such forward looking statements. DiaSys refers interested parties to its most recent Annual Report on form 10-KSB and other SEC filings for a complete description of, and discussions about, the company. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion